Marta Palafox

2.0k total citations · 1 hit paper
12 papers, 914 citations indexed

About

Marta Palafox is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Marta Palafox has authored 12 papers receiving a total of 914 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Marta Palafox's work include Advanced Breast Cancer Therapies (4 papers), Cancer-related Molecular Pathways (4 papers) and Microtubule and mitosis dynamics (2 papers). Marta Palafox is often cited by papers focused on Advanced Breast Cancer Therapies (4 papers), Cancer-related Molecular Pathways (4 papers) and Microtubule and mitosis dynamics (2 papers). Marta Palafox collaborates with scholars based in Spain, United States and United Kingdom. Marta Palafox's co-authors include Violeta Serra, Marta Guzmán, Javier Cortés, Meritxell Bellet, Christopher J. Lord, Martín A. Rivas, José Baselga, Richard Elliott, Lesley‐Ann Martin and María Teresa Herrera-Abreu and has published in prestigious journals such as Nature Communications, The Journal of Experimental Medicine and PLoS ONE.

In The Last Decade

Marta Palafox

11 papers receiving 903 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Early Adaptation and Acquired Resistance to CDK4/6 Inhibition in Estrogen Receptor–Positive Breast Cancer

2016 511 citations María Teresa Herrera-Abreu, Marta Palafox et al. Cancer Research profile →

Peers

Marta Palafox

ONCOL

PRM

MB

CR

GENET

Valerie M. Jansen United States

Chiara Biagioni Italy

Judit Grueso Spain

Shi Chang United States

Erin Trachet United States

W. Ruprecht Wiedemeyer United States

Josep-Lluís Parra Spain

Irina S. Babina United Kingdom

Vishnu Kumarasamy United States

Andrea Gombos Belgium

Valerie M. Jansen United States

Marta Palafox

583 ×1.0

ONCOL

479 ×1.0

PRM

304 ×0.8

MB

273 ×1.1

CR

124 ×0.8

GENET

Citations per year, relative to Marta Palafox Marta Palafox (= 1×) peers Valerie M. Jansen

Countries citing papers authored by Marta Palafox

Since Specialization

Citations

This map shows the geographic impact of Marta Palafox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Palafox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Palafox more than expected).

Fields of papers citing papers by Marta Palafox

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marta Palafox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Palafox. The network helps show where Marta Palafox may publish in the future.

Co-authorship network of co-authors of Marta Palafox

This figure shows the co-authorship network connecting the top 25 collaborators of Marta Palafox. A scholar is included among the top collaborators of Marta Palafox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta Palafox. Marta Palafox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Gómez‐Miragaya, Jorge, Maren Diepenbruck, Katrin Volkmann, et al.. (2025). Activated glucocorticoid receptor is an estrogen receptor silencer in ER+ metastatic breast cancer. EMBO Molecular Medicine. 18(1). 151–186.

2.

Hench, Jürgen, Maren Diepenbruck, Katrin Volkmann, et al.. (2024). BRCA promoter methylation in triple-negative breast cancer is preserved in xenograft models and represents a potential therapeutic marker for PARP inhibitors. Breast Cancer Research and Treatment. 209(2). 389–396. 1 indexed citations

3.

Rodriguez, María Jimena, Marina Riggio, Marta Palafox, et al.. (2023). Targeting mTOR to overcome resistance to hormone and CDK4/6 inhibitors in ER-positive breast cancer models. Scientific Reports. 13(1). 20 indexed citations

4.

Mateo, Lídia, Miquel Duran‐Frigola, Albert Gris‐Oliver, et al.. (2020). Personalized cancer therapy prioritization based on driver alteration co-occurrence patterns. Genome Medicine. 12(1). 78–78. 15 indexed citations

5.

Green, Jennifer L., Eric Okerberg, Marta Palafox, et al.. (2019). Direct CDKN2 Modulation of CDK4 Alters Target Engagement of CDK4 Inhibitor Drugs. Molecular Cancer Therapeutics. 18(4). 771–779. 30 indexed citations

6.

Palafox, Marta, Touati Benoukraf, Patrick Jaynes, et al.. (2018). Loss of USP28-mediated BRAF degradation drives resistance to RAF cancer therapies. The Journal of Experimental Medicine. 215(7). 1913–1928. 44 indexed citations

7.

Palafox, Marta, María Teresa Herrera-Abreu, Meritxell Bellet, et al.. (2018). Abstract 3596: Biomarkers of response to CDK4/6 inhibitor (CDK4/6i) in hormone receptor (HR) positive and HER2-positive breast cancer (BC) patient-derived xenografts (PDX). Cancer Research. 78(13_Supplement). 3596–3596. 1 indexed citations

8.

Méndez‐Pertuz, Marinela, Paula Martínez, Carmen Blanco‐Aparicio, et al.. (2017). Modulation of telomere protection by the PI3K/AKT pathway. Nature Communications. 8(1). 1278–1278. 57 indexed citations

9.

Herrera-Abreu, María Teresa, Marta Palafox, Uzma Asghar, et al.. (2016). Early Adaptation and Acquired Resistance to CDK4/6 Inhibition in Estrogen Receptor–Positive Breast Cancer. Cancer Research. 76(8). 2301–2313. 511 indexed citations breakdown →

10.

Blancafort, Adriana, Ariadna Giró‐Perafita, Glòria Oliveras, et al.. (2015). Dual Fatty Acid Synthase and HER2 Signaling Blockade Shows Marked Antitumor Activity against Breast Cancer Models Resistant to Anti-HER2 Drugs. PLoS ONE. 10(6). e0131241–e0131241. 54 indexed citations

11.

Palafox, Marta, Irene Ferrer, Pasquale Pellegrini, et al.. (2012). RANK Induces Epithelial–Mesenchymal Transition and Stemness in Human Mammary Epithelial Cells and Promotes Tumorigenesis and Metastasis. Cancer Research. 72(11). 2879–2888. 153 indexed citations

12.

Lasa, Marina, et al.. (2009). Thyroid Hormone Antagonizes Tumor Necrosis Factor-α Signaling in Pituitary Cells through the Induction of Dual Specificity Phosphatase 1. Molecular Endocrinology. 24(2). 412–422. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact